Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Tax Provisions (2017 - 2025)

Historic Tax Provisions for Fortress Biotech (FBIO) over the last 7 years, with Q3 2025 value amounting to $26000.0.

  • Fortress Biotech's Tax Provisions fell 7400.0% to $26000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $462000.0, marking a year-over-year decrease of 354.91%. This contributed to the annual value of $312000.0 for FY2024, which is 4011.52% down from last year.
  • As of Q3 2025, Fortress Biotech's Tax Provisions stood at $26000.0, which was down 7400.0% from $336000.0 recorded in Q4 2024.
  • Fortress Biotech's Tax Provisions' 5-year high stood at $500000.0 during Q4 2021, with a 5-year trough of $26000.0 in Q3 2025.
  • Moreover, its 5-year median value for Tax Provisions was $336000.0 (2024), whereas its average is $275857.1.
  • Its Tax Provisions has fluctuated over the past 5 years, first tumbled by 1020.0% in 2022, then tumbled by 7400.0% in 2025.
  • Over the past 5 years, Fortress Biotech's Tax Provisions (Quarter) stood at $500000.0 in 2021, then decreased by 10.2% to $449000.0 in 2022, then fell by 15.59% to $379000.0 in 2023, then dropped by 11.35% to $336000.0 in 2024, then crashed by 92.26% to $26000.0 in 2025.
  • Its Tax Provisions was $26000.0 in Q3 2025, compared to $336000.0 in Q4 2024 and $100000.0 in Q3 2024.